Detalhe da pesquisa
1.
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
N Engl J Med
; 387(9): 810-823, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36053506
2.
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 66(9): e0040822, 2022 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35916515
3.
Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis.
J Antimicrob Chemother
; 76(4): 1019-1024, 2021 03 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33378452
4.
Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artigo
Inglês
| MEDLINE | ID: mdl-32778547
5.
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
Antimicrob Agents Chemother
; 63(5)2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30858211
6.
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31061152
7.
The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation.
Int J Antimicrob Agents
; 62(4): 106939, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37517627